Concept explainers
a.
To explain: The reason for gene duplicates being so dead on arrival.
Introduction: The mechanism in which messenger RNA is reverse transcribed into DNA leading to the integration of DNA into the genome is called retrotransposition. The process results in the formation of duplicate genes which are different from the parental genome and also present on a different chromosome. Retrotransposition can result in the formation of pseudogenes.
a.
Explanation of Solution
Duplicative genes arising from retrotransposition does not have introns. However, due to the lack of introns, they can be easily distinguished from the parental genes, and they may not undergo post-transcriptional changes resulting in the death of the genes (pseudogenes). Therefore, that they are often dead on arrival.
b.
To explain: The duplicative genes obtained after unequal crossing over is more functional than gene arise by retrotransposition.
Introduction: The formation of duplicative genes can occur by unequal crossing over and through retrotransposition. Unequal crossing over results from misalignment of the chromosomes during meiosis ultimately leading to the process of recombination. Retrotransposition results in the formation of duplicate genes which are different from the parental genome and also present on a different chromosome. Unequal crossing over results in the formation of functional gene products while retrotransposition leads to the formation of pseudogenes.
b.
Explanation of Solution
The gene duplicates formed due to unequal crossing over is functional in nature as they have introns and exons. The gene duplicates are capable to undergo post-transcriptional modifications leading to the formation of functional protein. In case of retrotransposition gene duplicates does not have introns. However, due to lack of introns, they cannot undergo post-transcriptional modifications thereby resulting in nonfunctional gene product.
c.
To discuss: The ultimate fates of functional gene duplicates.
Introduction: The gene duplicates arising from different mechanisms after being fixed in a population can undergo several fates. The formation of duplicative genes can occur by unequal crossing over and through retrotransposition. The gene duplicates may lose their function due to deletion or may retain its original function.
c.
Explanation of Solution
Functional gene products arising from different mechanisms can undergo four different fates which are as follows:
- The redundancy of the gene duplicate may result in the deletion of the duplicate gene product.
- The gene duplicate may retain its original function. These duplicates are favored as they are able to retain their function due to which they can undergo the process of selection for increased gene expression.
- The duplicate gene product would evolve as the gene that is characterized by novel biological function.
- The parent gene along with duplicate gene products may subfunctionalize to perform the functions related to ancestral genes.
To determine: The most suitable fate of gene duplication.
Introduction: The gene duplicates arising from different mechanisms after being fixed in a population can undergo several fates. The formation of duplicative genes can occur by unequal crossing over and through retrotransposition. The gene duplicates may lose their function due to deletion or may retain its original function.
Explanation of Solution
The process of gene duplication resulting in retaining the original function of the gene is more likely to happen as the genes can undergo the process of selection for increased gene expression.
Want to see more full solutions like this?
Chapter 14 Solutions
Evolution
- a. Some antibiotics, such as rifampin, interfere with the function of RNA polymerase. What biological process is rifampin disrupting? b. Some antibiotic-resistant M. tuberculosis bacteria have a single point mutation (CàT) in the rpoB gene that causes an amino acid change from serine (a polar amino acid) to leucine (a non-polar amino acid). What type of mutation is this? Do you expect this to have no effect, a small effect, or a large effect on the polypeptide produced? Explain your reasoning. c. The rpoB gene encodes a subunit of the bacterial RNA polymerase protein. The point mutation described in Question 2 causes a change in protein folding, which leads to the inability of the rifampin antibiotic to bind to the RNA polymerase. Which level(s) of protein structure is/are affected by this change?arrow_forwardWhich of these two mechanisms might be promoted by thepresence of the same transposable element in many places in a species’ genome?arrow_forward1). In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder. You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH). a) Hypothetically, what specific type of VECTOR will you use to perform your gene therapy? Please select from the following list of potential vectors: disabled retrovirus, adenovirus, adeno-associated virus (AAV), or herpes simplex virus (HSV), then give two reasons why this specific vector is the most appropriate for your gene therapy. Please explain why you were able to rule out the other potential…arrow_forward
- 1). In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder. You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH). Please EXCLUDE the use of CRISPR from consideration. A. Will you use germline or somatic cell gene therapy? Please NAME and DEFINE the form of gene therapy selected, then explain WHY this is the most appropriate choice.arrow_forward1). In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder. You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH). Other scientists have suggested that it might be possible to use CRISPR to treat this genetic disorder in affected individuals. (i) First, what is CRISPR? (BRIEFLY describe what it is and how it works). (ii) Briefly describe how CRISPR could be utilized in treating genetic conditions such as Batten disease.arrow_forwardWith regard to gene duplications, which of the following statement(s) is/are correct?a. Gene duplications may be caused by nonallelic homologousrecombination.b. Large gene duplications are more likely to be harmful thansmaller ones.c. Gene duplications are responsible for creating gene familiesthat encode proteins with similar and specialized functions.d. All of the above statements are correct.arrow_forward
- Expression of recombinant proteins in yeast is an important tool for biotechnology companies that produce new drugs for human use. In an attempt to get a new gene X expressed in yeast, a researcher has integrated gene X into the yeast genome near a telomere. Will this strategy result in good expression of gene X? Why or why not? please try to explain a bit elaborately.arrow_forwardHuntington’s disease is a hereditary central nervous system disorder characterized by tandem repeats of the sequence 5'-CAG-3' in the gene that encodes a protein called huntingtin. The disease is progressive from generation to generation, meaning that in later generations the number of CAG repeats increases and the age of onset of symptoms decreases. Refer to Figure 21.4 and describe the sort of evidence supporting the generational increase in the number of CAG repeats.arrow_forwardExposure to various chemicals can cause DNA mutations. Classify the examples as representative of transition, transversion, or nsertion/deletion mutations. Transition replacement of T:A: with C:G treatment with nitrogen mustard causes this type of mutation oxidative deamination via nitrous acid causes this type of mutation treatment with 5-bromouracil causes the replacement of A:T with G:C Transversion replacement of G:C with T:A Answer Bank Insertion/Deletion the removal of one or more base pairs treatment with proflavin causes this type of mutationarrow_forward
- a. Why is it impossible to induce nonsense mutations(represented at the mRNA level by the triplets UAG,UAA, and UGA) by treating wild-type strains with mutagens that cause only A• G → T• C transitions in DNA?b. Hydroxylamine (HA) causes only G• C → A• T transitions in DNA. Will HA produce nonsense mutations inwild-type strains?c. Will HA treatment revert nonsense mutations?arrow_forwardExpression of recombinant proteins in yeast is an important tool for biotechnology companies that produce new drugs for human use. In an attempt to get a new gene X expressed in yeast, a researcher has integrated gene X into the yeast genome near a telomere. Will this strategy result in good expression of gene X? Why or why not? Would the outcome of this experiment differ if the experiment had been performed in a yeast line containing mutations in the H3 or H4 histone tails?arrow_forwardDeletions in bacterial chromosomes give the following data: Region of deletion Al Gene A activity +++ A2 АЗ A4 AS +++ (i) Where is the gene located? Explain your answer. Name the scientific term that describes the appearance of a recessive phenotype due to deletion of dominant gene. (ii) (iii) The phenotypic consequences of deletion depend on two factors. What are they? Give one example of human genetic disorder caused by chromosomal deletion by indicating the region of deletion in chromosome. (iv)arrow_forward
- Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSONBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxAnatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
- Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & CompanyLaboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education